Tomoko Tadokoro, Takako Nomura, Koji Fujita, Takushi Manabe, Kei Takuma, Mai Nakahara, Kyoko Oura, Shima Mimura, Joji Tani, Asahiro Morishita, et al. Management of hepatocellular carcinoma, an important cause of death in Japanese autoimmune hepatitis patients. BMC gastroenterology. 2024. 24. 1. 123-123
Tomoko Tadokoro, Kyoko Oura, Kei Takuma, Mai Nakahara, Koji Fujita, Shima Mimura, Joji Tani, Asahiro Morishita, Masafumi Ono, Takashi Himoto, et al. 亜鉛製剤の長期投与中に急激な血球減少・末梢神経障害を生じた肝硬変患者の一例. Kanzo. 2024. 65. 1. 25-30
Kyoko Oura, Asahiro Morishita, Kei Takuma, Mai Nakahara, Tomoko Tadokoro, Koji Fujita, Shima Mimura, Joji Tani, Masafumi Ono, Takashi Himoto, et al. Efficacy and outcome of molecular targeted therapies in elderly patients with hepatocellular carcinoma: Relative dose intensity associated with overall survival. Cancer medicine. 2023
Shima Mimura, Koji Fujita, Kei Takuma, Mai Nakahara, Kyoko Oura, Tomoko Tadokoro, Joji Tani, Asahiro Morishita, Masafumi Ono, Takashi Himoto, et al. Predictors of therapeutic response to peginterferon α-2a and nucleos(t)ide analog combination therapy for HBeAg-negative chronic hepatitis B: 1-year follow-up after treatment. Experimental and therapeutic medicine. 2023. 26. 6. 587-587
Kyoko Oura, Asahiro Morishita, Takushi Manabe, Kei Takuma, Mai Nakahara, Tomoko Tadokoro, Koji Fujita, Shima Mimura, Joji Tani, Masafumi Ono, et al. Relationship between Accurate Diagnosis of Sarcopenia and Prognosis in Patients with Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab Combination Therapy. Cancers. 2023. 15. 12